Background: Congenital myopathies (CMs) are a genetically and clinically heterogeneous group of neuromuscular disorders. Historically, the congenital myopathies are classified according to muscle biopsy findings -Rods (Nemaline myopathy) (NM), cores (central core disease and multiminicore disease) (Core and MMC), central nuclei (centronuclear/ myotubular myopathy)(CNM) , and selective hypotrophy of type 1 fibres ( congenital fibre type disproportion CFD). Over twenty genes have been implicated in CMs. The overlapping clinical presentations among different histopathological findings and different mutations poses major diagnostic challenge.
Objective:
We investigated the characteristics of children with congenital myopathies in Hong Kong.
Patients and methods:
We identified all patients with a confirmed diagnosis of CM between 2012-March 2015. Their clinical presentation , muscle biopsy, muscle MRI and genetic analysis results were evaluated.
Results:

Patients:
Total 15 patients have been diagnosed to have CM. Nine were males (60%), 6 were female (40%).
Genetic findings:
(1)
A genetic diagnosis could be established in 11 (73%) out of 15 patients. Among those 11 patients, 4 (36%) were mutated in RYR1, 3 (27%) in ACTA1, 2 (18%) in KLHL40 , 1 (9%) in MTM1 and 1 (9%) in DNM2. A total of 13 mutation were identified.
The missense RYR1 mutation (c.3523G>A) was found in 2 patients, and the missense KLHL40 mutation (c.1516A>C) was found in another 2 patients, suggesting that these variants could probably be the hot spots mutation among Chinese patients.
Pathological heterogeneity caused by RYR1 mutation is shown in our 4 patients showing different findings including nemaline rods, central cores, multiminicores, or type 1 fibre predominance.
Histopathological features:
(1) Muscle biopsy evaluation were available in all 15 patients. Nemaline myopathy were the most frequent histopathological diagnosis, in 5 patients (33%), followed by core myopathy, in 4 patients (26%), centronuclear myopathy in 2 patients (13%), congenital fibre type disproportion in 2 patients (13%), zebra bodies in 1 (6.7%) patient and type 1 predominance in 1 (6.7 %) patient. (2) Genetic heterogeneity is illustrated in our patients with nemaline myopathy. Amongst the 5 patients, 1 had RYR1, 2 had ACTA1 and 2 had KLHL40 mutation.
Clinical features:
(1) Of the 15 patients, 9 (60%) had age of onset at birth or before one month, 3 (20%) between 1 and 12 months, and 3 (20%) between 1 and 5 years. Out of the 9 patients with early neonatal presentation, 3/9 (33%) patients died before 13 months. (2) The functional abilities varied from very severe weakness required tube feeding and ventilation support , to intermediate functional abilities with possible independent sitting , to mild limb girdle weakness only. 
Muscle imaging:
Selective muscle involvement with Rectus Femoris sparing provides helpful clues to a possible underlying RYR1 mutation. 
